Stephan R. Targan
Directeur/Membre du Conseil chez Alimentiv, Inc.
Profil
Stephan R.
Targan is the founder of Prometheus Laboratories, Inc. founded in 1995.
He is currently a Director at Prometheus RxDx, Inc. since 2009 and a Director at Alimentiv, Inc. He was also a Professor at the University of California, Los Angeles since 1978.
Dr. Targan received his undergraduate and doctorate degrees from The Johns Hopkins University.
Postes actifs de Stephan R. Targan
| Sociétés | Poste | Début |
|---|---|---|
| University of California, Los Angeles | Corporate Officer/Principal | 01/01/1978 |
Prometheus RxDx, Inc.
 Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | Directeur/Membre du Conseil | 01/06/2009 |
Alimentiv, Inc.
 Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephan R. Targan
| Sociétés | Poste | Fin |
|---|---|---|
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Fondateur | - |
Formation de Stephan R. Targan
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Prometheus RxDx, Inc.
Prometheus RxDx, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Prometheus RxDx, Inc. engages in the development and commercialization of pharmaceutical and diagnostic products. The company is based in San Diego, CA. | Health Technology |
Alimentiv, Inc.
Alimentiv, Inc. Pharmaceuticals: MajorHealth Technology Alimentiv, Inc. is a contract research organization that provides clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Alimentiv is committed to medical research and development, with a focus on identifying barriers to drug development and pursuing solutions that advance inflammatory bowel disease (IBD) research. Alimentiv employs over 450 people across its operations in the US, Canada, Europe, and Asia. The Canadian company's unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. The private company was founded in 1986 at the Robarts Research Institute and is headquartered in London, CA. Jeff Smith has been the CEO of the company since 2016. | Health Technology |
